European Union Projects

Investment projects in Production Equipment for the development of the project to diversify the manufacturing activity of pharmaceutical specialties (IG227.2016.1.101).


Biofabri is supported by CDTI to carry out R&D projects that fund research related to COVID-19. Our company, in collaboration with CSIC, has carried out a project in the field of human vaccines called: “DESARROLLO DE UNA VACUNA DE ADN FRENTE AL CORONAVIRUS SARS-COV-2”.

This project has been co-financed by the European Regional Development Fund (ERDF), a way of making Europe. The main objective of this project is the design and development of an effective and safe third generation vaccine (recombinant DNA) against SARS-CoV-2 containing the genes encoding the subunits of the SARS-CoV-2 spicule protein (protein S) and essential fragments of the same. This project was carried out at the company’s headquarters in O Porriño, Galicia. Its execution schedule was between June and December 2020. The project budget was 608,026 € and was supported by CDTI and ERDF funds.